Inventor · disambiguated record
Elliot Altman
Also filed as: ALTMAN ELLIOT
25 granted patents·17 pending applications·334 citations·filing 1999–2023
95Inventor score
Files withTRINITY THERAPEUTICS INC8UNIV GEORGIA RES FOUND7BODIE NEIL M6MIDDLE TENNESSEE STATE UNIV5EITEMAN MARK A3
Top patents by PatentIndex Score
42 records- 0196US6455284B1Metabolically engineered E. coli for enhanced production of oxaloacetate-derived biochemicalsUNIV GEORGIA RES FOUND·Filed 1999·Granted Sep 24, 2002·164 cites·10 claims
- 0294US7749740B2Microbial production of pyruvate and pyruvate derivativesUNIV GEORGIA·Filed 2004·Granted Jul 6, 2010·48 cites·64 claims
- 0394US7365162B2Stabilized bioactive peptides and methods of identification, synthesis, and useUNIV GEORGIA RES FOUND·Filed 2005·Granted Apr 29, 2008·16 cites·6 claims
- 0485US8030464B2Stabilized bioactive peptides and methods of identification, synthesis, and useUNIV GEORGIA·Filed 2008·Granted Oct 4, 2011·3 cites·22 claims
- 0585US7714104B2Methods for inhibiting immune complex formation in a subjectTRINITY THERAPEUTICS INC·Filed 2006·Granted May 11, 2010·7 cites·18 claims
- 0685US7122516B2Stabilized bioactive peptides and methods of identification, synthesis and useUNIV GEORGIA RES FOUND·Filed 2004·Granted Oct 17, 2006·18 cites·22 claims
- 0785US6916904B2Inhibition of immune complex formationZOLARIS BIOSCIENCES LLC·Filed 2002·Granted Jul 12, 2005·20 cites·37 claims
- 0884US8652825B2Microbial production of pyruvate and other metabolitesEITEMAN MARK A·Filed 2012·Granted Feb 18, 2014·4 cites·9 claims
- 0982US7786258B2Methods for inhibiting immune complex formation in a subjectTRINITY THERAPEUTICS INC·Filed 2006·Granted Aug 31, 2010·4 cites·23 claims
- 1081US8278076B2Microbial production of pyruvate and pyruvate derivativesEITEMAN MARK A·Filed 2010·Granted Oct 2, 2012·3 cites·16 claims
- 1180US6818611B1Stabilized bioactive peptides and methods of identification, synthesis and useUNIV GEORGIA RES FOUND·Filed 1999·Granted Nov 16, 2004·41 cites·20 claims
- 1278US10018618B2Stabilizied bioactive peptides and methods of identification, synthesis and usePEPTIDE BIOSCIENCES INC·Filed 2016·Granted Jul 10, 2018·1 cites·8 claims
- 1377US8551758B2Substrate-selective co-fermentation processEITEMAN MARK A·Filed 2009·Granted Oct 8, 2013·2 cites·5 claims
- 1475US8362202B2Methods for inhibiting immune complex formation in a subjectTRINITY THERAPEUTICS INC·Filed 2010·Granted Jan 29, 2013·2 cites·14 claims
- 1571US9447145B2Compositions for inhibiting immune complex formation in a subjectTRINITY THERAPEUTICS INC·Filed 2013·Granted Sep 20, 2016·1 cites·16 claims
- 1669US2010068753A1Biotin-facilitated transport in gram negative bacteriaUNIV GEORGIA·Filed 2009·Application pending·0 cites
- 1766US2018313820A1Stabilized bioactive peptides and methods of identification, synthesis, and usePEPTIDE BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 1864US9322829B2Stabilized bioactive peptides and methods of identification, synthesis, and usePEPTIDE BIOSCIENCES INC·Filed 2013·Granted Apr 26, 2016·0 cites·7 claims
- 1963US11007169B2Cis-gnetin H and trans-gnetin H as therapeutic agentsMIDDLE TENNESSEE STATE UNIV·Filed 2019·Granted May 18, 2021·0 cites·10 claims
- 2063US2003190740A1Stabilized bioactive peptides and methods of identification, synthesis, and useUNIV GEORGIA RES FOUND·Filed 2002·Application pending·0 cites
- 2161US10179803B2Methods for inhibiting immune complex formation in a subjectTRINITY THERAPEUTICS INC·Filed 2016·Granted Jan 15, 2019·0 cites·4 claims
- 2259US11980648B2Compositions including ginsenoside 20(S)-Rg3 and methods of using ginsenoside 20(S)-Rg3 to inhibit alpha herpesvirusMIDDLE TENNESSEE STATE UNIV·Filed 2021·Granted May 14, 2024·0 cites·20 claims
- 2359US2009105138A1Methods for treating immune mediated neurological diseasesTRINITY THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2458US2017065670A1Methods for treating immune mediated neurological diseasesTRINITY THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2557US8440201B2Stabilized bioactive peptides and methods of identification, synthesis, and useALTMAN ELLIOT·Filed 2011·Granted May 14, 2013·0 cites·21 claims
- 2655US12496307B2Cannabinoid compositions and methods of usingGREENWAY HERBAL PRODUCTS LLC·Filed 2020·Granted Dec 16, 2025·0 cites·6 claims
- 2754US10993920B22-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione as a cancer therapeuticMIDDLE TENNESSEE STATE UNIV·Filed 2015·Granted May 4, 2021·0 cites·9 claims
- 2854US2008187490A1Methods for Treating Amyotrophic Lateral SclerosisBODIE NEIL M·Filed 2006·Application pending·0 cites
- 2954US2008200392A1Methods for Treating Parkinson's DiseaseBODIE NEIL M·Filed 2006·Application pending·0 cites
- 3054US2008207498A1Methods for Treating Alzheimer's DiseaseBODIE NEIL M·Filed 2006·Application pending·0 cites
- 3152US2012115791A1Methods for Treating Immune Mediated Neurological DiseasesBODIE NEIL M·Filed 2012·Application pending·0 cites
- 3249US7584059B2Inhibition of immune complex formationTRINITY THERAPEUTICS INC·Filed 2005·Granted Sep 1, 2009·0 cites·24 claims
- 3347US2023248747A1Cannabinoid and omega fatty acid compositions and methods of usingGREENWAY HERBAL PRODUCTS LLC·Filed 2023·Application pending·0 cites
- 3447US2023015268A1Cannabinoid and omega fatty acid compositions and methods of usingGREENWAY HERBAL PRODUCTS LLC·Filed 2022·Application pending·0 cites
- 3546US2003087381A1Metabolically engineered organisms for enhanced production of oxaloacetate-derived biochemicalsUNIV GEORGIA RES FOUND·Filed 2002·Application pending·0 cites
- 3644US7601511B2Biotin-facilitated transport in gram negative bacteriaUNIV GEORGIA RES FOUND·Filed 2004·Granted Oct 13, 2009·0 cites·18 claims
- 3743US2012021988A1Methods for treating immune thrombocytopeniaBODIE NEIL M·Filed 2008·Application pending·0 cites
- 3843US2018221329A1Cis- and trans-suffruticosol d as therapeutic agentsMIDDLE TENNESSEE STATE UNIV·Filed 2016·Application pending·0 cites
- 3941US2007249018A1Reduced overflow metabolism and methods of useVEMURI GOUTHAM·Filed 2007·Application pending·0 cites
- 4036US2017326098A1Cis-gnetin h and trans-gnetin h as therapeutic agentsMIDDLE TENNESSEE STATE UNIV·Filed 2015·Application pending·0 cites
- 4135US9212346B2Substrate-selective co-fermentation processEITEMAN MARK·Filed 2010·Granted Dec 15, 2015·0 cites·16 claims
- 4232US2017360875A1Methods for treating immune-mediated viral infectionsBODIE NEIL M·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elliot Altman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →